Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C

Hepatology

Volumn 42, Issue 4, 2005, Pages 846-853

  Kato, Naoya ^a,d   Ji, Guijin ^b   Wang, Yue ^a   Baba, Masanori ^b   Hoshida, Yujin ^a   Otsuka, Motoyuki ^a   Taniguchi, Hiroyoshi ^a   Moriyama, Masaru ^a   Dharel, Narayan ^a   Goto, Tadashi ^a   Shao, Run Xuan ^a   Matsuura, Tadashi ^b   Ishii, Keisuke ^b   Shiina, Shuichiro ^a   Kawabe, Takao ^a   Muramatsu, Masaaki ^b,c   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b HuBit Genomix Research Institute   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CRHR2 GENE; FEMALE; GENE; GENETIC MARKER; GENETIC SCREENING; GFRA1 GENE; HAPLOTYPE; HEPATITIS C; HEREDITY; HOST; HUMAN; HUMAN TISSUE; JAPANESE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCYB14 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOKINES, CXC; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HAPLOTYPES; HEPATITIS C, CHRONIC; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RISK FACTORS;

EID: 25844525823     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20860     Document Type: Article

References (33)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl Med 2001;345:41-52.
2. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. HEPATOLOGY 1995;22:1027-1033.
3. Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O, et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med 2000;132:517-524.
4. Yoshida H, Arakawa Y, Sata M, Nishiguchi S, Yano M, Fujiyama S, et al. Interferon therapy prolonged life expectancy among chronic hepatitis C patients. Gastroenterology 2002;123:483-491.
5. Seeff LB. Natural history of chronic hepatitis C. HEPATOLOGY 2002;36:s35-s46.
6. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. HEPATOLOGY 1999;30:595-601.
7. Desmet VJ. Histopathology of chronic hepatitis. In: Liaw YF, ed. Chronic Hepatitis. Amsterdam: Elsevier, 1986:27-44.
8. Yeh SH, Chen PJ, Shau WY, Chen YW, Lee PH, Chen JT, et al. Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 2001;121:699-709.
9. Chau TKH, Murakami S, Kawai B, Nasu K, Kubota T, Ohnishi A. Genotype analysis of the CYP2C19 gene in HCV-seropositive patients with cirrhosis and hepatocellular carcinoma. Life Sci 2000;67:1719-1724.
10. Vogel A, Kneip S, Barut A, Ehnter U, Tukey RH, Manns MP, et al. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP- glucuronosyltransferase UGT1A7 gene. Gastroenterology 2001;121:1136-1144.
11. Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, et al. Interleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. HEPATOLOGY 2003;37:65-71.
12. Wang Y, Kato N, Hoshida Y, Otsuka M, Taniguchi H, Moriyama M, et al. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in Japanese patients with hepatitis C. virus infection. Clin Cancer Res 2004;10:2441-2446.
13. Silvestri L, Sonzogui L, Silvestri AD, Gritti C, Foti L, Zavaglia C, et al. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. Int J Cancer 2003;104:310-317.
14. Sonzogui L, Silvestri L, Silvestri AD, Gritti C, Foti L, Zavaglia C, et al. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease. HEPATOLOGY 2002;36:195-201.
15. Kato S, Tajiri T, Matsukura N, Matsuda N, Taniai N, Mamada H, et al. Genetic polymorphisms of aldehyde dehydrogenase 2, cytochrome p450 2E1 for liver cancer risk in HCV antibody-positive Japanese patients and the variations of CYP2E1 mRNA expression levels in the liver due to its polymorphism. Scand J Gastroenterol 2003;38:886-893.
16. Hara K, Ohe K, Kadowaki T, Kato N, Imai Y, Tokunaga K, et al. Establishment of a method of anonymization of DNA samples in genetic research. J Hum Genet 2003;48:327-330.
17. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. HEPATOLOGY 1992;15:567-571.
18. Hirakawa M, Tanaka T, Hashimoto Y, Kuroda M, Takagi T, Nakamura Y. JSNP: a database of common gene variations in the Japanese population. Nucl Acids Res 2002;30:158-162.
19. Ranade K, Chang MS, Ting CT, Pei D, Hsiao CF, Olivier M, et al. High-throughput genotyping with single nucleotide polymorphism. Genome Res 2001;11:1262-1268.
20. Daimon M, Ji G, Saitoh T, Oizumi T, Tominaga M, Nakamura T, et al. Large-scale search of SNPs for type 2 DM susceptibility genes in a Japanese population. Biochem Biophys Res Commun 2003;302:751-758.
21. Kitamura Y, Moriguchi M, Kaneko H, Morisaki H, Morisaki T, Toyama K, et al. Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann Hum Genet 2002;66:183-193.
22. Zhao JH, Sham PC. Faster allelic association analysis using unrelated subjects. Hum Hered 2002;53:36-41.
23. Risch N, Merikangas K. The Future of Genetic Studies of Complex Human Diseases. Science 1996;273:1516-1567.
24. Carrington JC, Ambros V. Role of microRNAs in plant and animal development. Science 2003;301:336-338.
25. Hromas R, Broxmeyer HE, Kim C, Nakshatri H, Christopherson K, Azam M, et al. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun 1999;255:703-706.
26. Schwarze SR, DePrimo SE, Grabert LM, Fu VX, Brooks JD, Jarrard DF. Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J Biol Chem 2002;277:14877-14883.
27. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 2000;24:403-409.
28. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 2000;24:410-414.
29. Yokohama S, Yoneda M, Watanobe H, Kono T, Nakamura K, Makino I, et al. Effect of central urocortin on carbon tetrachloride-induced acute liver injury in rats. Neurosci Lett 2001;313:149-152.
30. Chatzaki E, Charalampopoulos I, Leontidis C, Mouzas IA, Tzardi M, Tsatsanis C, et al. Urocortin in human gastric mucosa: relationship to inflammatory activity. J Clin Endocrinol Metab 2003;88:478-483.
31. Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. for IHIT study group. Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 1999;131:174-181.
32. Angrist M, Jing S, Bolk S, Bentley K, Nallasamy S, Halushka M, et al. Human GFRA1: Cloning, mapping, genomic structure, and evaluation as a candidate gene for Hirschsprung disease susceptibility. Genomics 1998;48:354-362.
33. Gimm O, Dziema H, Brown J, Hoang-Vu C, Hinze R, Dralle H, et al. Over-representation of a germline variant in the gene encoding RET co-receptor GFRalpha-1 but not GFRalpha-2 or GFRalpha-3 in cases with sporadic medullary thyroid carcinoma. Oncogene 2001;20:2161-2170.